• G00111

• 2.4.3.2
• 2.4.3.8
• 2.4.99.-
• 3.2.1.18

• 15546874
• 7553668

RES
1b:b-dglc-HEX-1:5
2b:b-dgal-HEX-1:5
3b:a-dgro-dgal-NON-2:6|1:a|2:keto|3:d
4s:n-acetyl
5b:b-dgal-HEX-1:5
6s:n-acetyl
7b:b-dgal-HEX-1:5
8b:a-dgro-dgal-NON-2:6|1:a|2:keto|3:d
9s:n-acetyl
LIN
1:1o(4+1)2d
2:2o(3+2)3d
3:3d(5+1)4n
4:2o(4+1)5d
5:5d(2+1)6n
6:5o(3+1)7d
7:7o(3+2)8d
8:8d(5+1)9n

• Townson K et al. Sulfatide binding properties of murine and human antiganglioside antibodies. Glycobiology. 2007 Nov;17:(11):1156-66. doi: 10.1093/glycob/cwm095. PMID: 17855742.

• Gong Y et al. Localization of major gangliosides in the PNS: implications for immune neuropathies. Brain. 2002 Nov;125:(Pt 11):2491-506. doi: 10.1093/brain/awf258. PMID: 12390975.

• Kotani M et al. Developmental changes of ganglioside expressions in postnatal rat cerebellar cortex. Brain Res. 1995 Nov 27;700:(1-2):40-58. doi: 10.1016/0006-8993(95)00923-e. PMID: 8624728.

• Vinson M et al. Myelin-associated glycoprotein interacts with ganglioside GT1b. A mechanism for neurite outgrowth inhibition. J Biol Chem. 2001 Jun 8;276:(23):20280-5. doi: 10.1074/jbc.M100345200. PMID: 11279053.

• Yamaguchi H et al. Cell-surface antigens of melanoma recognized by human monoclonal antibodies. Proc Natl Acad Sci U S A. 1987 Apr;84:(8):2416-20. doi: 10.1073/pnas.84.8.2416. PMID: 3031684.

• Kawashima I et al. Immunocytochemical analysis of gangliosides in rat primary cerebellar cultures using specific monoclonal antibodies. Brain Res. 1996 Sep 2;732:(1-2):75-86. doi: 10.1016/0006-8993(96)00493-3. PMID: 8891271.

• Boffey J et al. Characterisation of the immunoglobulin variable region gene usage encoding the murine anti-ganglioside antibody repertoire. J Neuroimmunol. 2005 Aug;165:(1-2):92-103. doi: 10.1016/j.jneuroim.2005.04.011. PMID: 15967512.

• Lunn MP et al. High-affinity anti-ganglioside IgG antibodies raised in complex ganglioside knockout mice: reexamination of GD1a immunolocalization. J Neurochem. 2000 Jul;75:(1):404-12. doi: 10.1046/j.1471-4159.2000.0750404.x. PMID: 10854286.

• Kotani M et al. Generation of one set of monoclonal antibodies specific for a-pathway ganglio-series gangliosides. Biochim Biophys Acta. 1992 Jul 21;1117:(1):97-103. doi: 10.1016/0304-4165(92)90168-t. PMID: 1627599.

• Kotani M et al. Differential distribution of major gangliosides in rat central nervous system detected by specific monoclonal antibodies. Glycobiology. 1993 Apr;3:(2):137-46. doi: 10.1093/glycob/3.2.137. PMID: 8490240.

• Schnaar RL et al. Immunoglobulin G-class mouse monoclonal antibodies to major brain gangliosides. Anal Biochem. 2002 Mar 15;302:(2):276-84. doi: 10.1006/abio.2001.5540. PMID: 11878808.

• Hildebrandt H et al. Antigen binding of antiganglioside antibodies in vitro is strongly influenced by the ganglioside composition of the sample. FEBS Lett. 1996 Jun 10;388:(1):29-33. doi: 10.1016/0014-5793(96)00503-0. PMID: 8654583.

• Ravindranath MH et al. Gangliosides of organ-confined versus metastatic androgen-receptor-negative prostate cancer. Biochem Biophys Res Commun. 2004 Nov 5;324:(1):154-65. doi: 10.1016/j.bbrc.2004.09.029. PMID: 15464996.

• Furukawa K et al. Two human monoclonal antibodies reacting with the major gangliosides of human melanomas and comparison with corresponding mouse monoclonal antibodies. Cancer Res. 1989 Jan 1;49:(1):191-6. PMID: 2908845.